Search is Powered by Google
Lymphoma / Leukemia News

Protein Mutated In Shwachman-Diamond Syndrome Provides Stability

Main Category: Lymphoma / Leukemia
Also Included In: Genetics
Article Date: 07 Mar 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Health Professional:5 stars

5 (2 votes)

Article Opinions: 0 posts

Shwachman-Diamond syndrome (SDS) is an inherited disorder, caused by genetic mutations in the SBDS gene and characterized by, among other things, bone marrow failure and an increased risk of acute myeloid leukemia. New insight into the mechanisms underlying these symptoms has now been generated by a team of researchers from Children's Hospital Boston and the University of Washington, Seattle, who analyzed human bone marrow stromal cells (BMSCs) and skin fibroblasts.

In BMSCs from healthy individuals the SBDS protein was found to be located at the mitotic spindle, a structure that forms when a cell is dividing, where it bound to and stabilized microtubules, protein filaments that function as structural components of a cell. Consistent with a role for SBDS in mitotic spindle stability, BMSCs from individuals with SDS exhibited increased abnormal mitosis. Further studies using drugs that modify microtubule stability supported this idea and led the authors to suggest that microtubule-stabilizing agents might provide a new approach to the treatment of individuals with SDS.

TITLE: Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome

AUTHOR CONTACT:
Akiko Shimamura
University of Washington, Seattle, Washington, USA.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Source: Karen Honey
Journal of Clinical Investigation




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Monitoring CML image Monitoring CML

A wide range of laboratory tests is used to monitor a patient's response to therapy for chronic myeloid leukemia. Listen to experts explain the tests and their range of sensitivity...

View more videos...